Two researchers at the Montreal Neurological Institute and Hospital (MNI) of 麻豆AV have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.
Category:
Published on: 24 Nov 2016
MNI scientists will study stem cells, genetic mutations to develop new treatments
Researchers at the Montreal Neurological Institute of 麻豆AV who are playing key roles in uncovering the mechanisms underlying ALS will share in $3.9 million in research funding, part of $4.5 million announced on Nov. 23 by the ALS Society of Canada in partnership with Brain Canada.
Category:
Published on: 23 Nov 2016
When two people smell the same thing, they can have remarkably different reactions, depending on their cultural background. Researchers at the Neuro have found that even when two cultures share the same language and many traditions, their reactions to the same smells can be different.
Category:
Published on: 21 Nov 2016
Scientists have identified a gene in the French-Canadian population that predisposes them to the development of intracranial aneurysm (IA), a potentially life threatening neurological condition that is responsible for approximately 500,000 deaths worldwide per year, half of which occur in people less than 50 years of age.
Using genetic analysis, the team of researchers found rare variations of one gene, RNF213, that appeared more frequently in IA patients than in the control group. Both patients and the control group came from French-Canadian families.
Category:
Published on: 31 Oct 2016
You probably know someone who has it. It is the most common movement disorder, yet most people don鈥檛 even know its name.
Essential tremor affects nearly one per cent of the world鈥檚 population, increasing to four per cent of those over 40. The involuntary shaking of hands is the most common symptom, but symptoms can also include shaking of the head and legs.
Category:
Published on: 21 Oct 2016
The Montreal Neurological Institute and Hospital (The Neuro) is pleased to announce a new initiative designed to ease the suffering of seriously ill patients through specialized consultation and comprehensive care.
The Susan Cameron Cook Neuro-Palliative Care Program, named in honour of Susan Cameron Cook, whose family provided vital seed funding for this initiative, has the goal of reducing the mental and physical suffering of neurological patients and their families in the journey from diagnosis of a terminal illness to end of life.
Category:
Published on: 17 Oct 2016
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital at 麻豆AV and the 麻豆AV Health Centre, has been chosen to receive another major award recognizing his outstanding scientific career. The national organization representing Canadian francophone doctors, M茅decins francophones du Canada, is bestowing on him its 2016 Prix de l鈥檕euvre scientifique.
Category:
Published on: 13 Oct 2016
Inspiring event to raise money for brain cancer research
An evening filled with personal stories from those whose lives have been affected by brain cancer will once again contribute to the fight against the disease.
Published on: 4 Oct 2016
A project led by an MNI researcher has been awarded $6.1 million to study progressive multiple sclerosis.
The International Progressive MS Alliance has awarded three $6.1 million Collaborative Network Award grants for a total investment of $18.4 million toward accelerating the pace of progressive MS research. More than 2.3 million people worldwide live with MS and more than one million of those living with the disease have progressive MS.
Category:
Published on: 20 Sep 2016
Fundraiser to support research to help defeat cancer suffered by Tragically Hip frontman
听
With the farewell concert of legendary Canadian band The Tragically Hip now past, The Neuro is asking the public to not forget the toll brain cancers take on Canadians, and the need to find new therapies.
Category:
Published on: 31 Aug 2016
Chemicals shown to improve low-light vision of tadpoles by sensitizing retinal cells
A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.
Category:
Published on: 25 Aug 2016
3D depth-sensing camera shown to measure walking difficulties
A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients.
The Microsoft Kinect is a 3D depth-sensing camera used in interactive video activities such as tennis and dancing. It can be hooked up to an Xbox gaming console or a Windows computer.
Published on: 15 Aug 2016
Research underlines importance of computational power in future neurological breakthrough
Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset 础濒锄丑别颈尘别谤鈥檚 disease (LOAD), identifying its first physiological signs.
Category:
Published on: 11 Jul 2016
A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at 麻豆AV have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.
Using both cellular and mouse models, the team has shown that proteins produced by the two genes, known as PINK1 and Parkin, are required to prevent cells from being detected and attacked by the immune system.
Category:
Published on: 27 Jun 2016
The opioid pain-reliever tramadol appears to be associated with an increased risk of hospitalization for hypoglycemia, a potentially fatal condition caused by low blood sugar, according to a report published online by JAMA Internal Medicine.
Category:
Published on: 8 Dec 2014
Pages
